Skip to Content

Tenet Healthcare Corp

View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation

Tenet Earnings: Continued Deleveraging Enhances Balance Sheet for Portfolio Transformation

No-moat Tenet Healthcare posted robust first-quarter results thanks to favorable medical utilization trends and effective cost controls. We are maintaining our $104 fair value estimate, as the company continues to optimize its portfolio through hospital divestitures and ambulatory care expansions. With recent deleveraging efforts, Tenet has significantly improved its balance sheet quality, which puts the company closer to its goal of operating 575-600 ambulatory facilities by the end of 2025. Currently, we view Tenet’s shares as fairly valued.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of THC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center